{"id":109752,"date":"2025-08-01T08:14:09","date_gmt":"2025-08-01T08:14:09","guid":{"rendered":"https:\/\/www.europesays.com\/us\/109752\/"},"modified":"2025-08-01T08:14:09","modified_gmt":"2025-08-01T08:14:09","slug":"fda-approves-alhemo-as-once-daily-prophylactic-treatment-to-prevent-or-reduce-the-frequency-of-bleeding-episodes-for-adults-and-children-12-years-of-age-and-older-with-hemophilia-a-or-b-ha-hb","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/109752\/","title":{"rendered":"FDA approves Alhemo\u00ae as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA\/HB) without inhibitors – PR Newswire"},"content":{"rendered":"
    \n
  1. FDA approves Alhemo\u00ae as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA\/HB) without inhibitors<\/a>  PR Newswire<\/li>\n
  2. European Medicines Agency Issues Positive Opinion for Concizumab Label Update in Hemophilia<\/a>  Docwire News<\/li>\n
  3. Novo Nordisk (NVO) Gains Positive CHMP Nod for Alhemo Label Expa<\/a>  GuruFocus<\/li>\n
  4. Novo Nordisk\u2019s Alhemo Recommended for Expanded Use in Europe for Haemophilia A and B<\/a>  Insider Monkey<\/li>\n
  5. FDA approves concizumab-mtci for hemophilia A\/B without inhibitors in patients 12 years and older<\/a>  Contemporary Pediatrics<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"FDA approves Alhemo\u00ae as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults…\n","protected":false},"author":3,"featured_media":201,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[210,1060,67,132,68],"class_list":{"0":"post-109752","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/114952514078333519","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/109752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=109752"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/109752\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/201"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=109752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=109752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=109752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}